Tresiba in the morning, with action overlap from the previous day's dose in the morning, could work for me. But it is not funded here (New Zealand). Lantus and NPH are the only basal insulin options. Filling the gap with Actrapid, which is funded, works well enough. But I suspect there are a lot...